These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1447752)

  • 21. 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands.
    Bernotas R; Lenicek S; Antane S; Zhang GM; Smith D; Coupet J; Harrison B; Schechter LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5499-502. PubMed ID: 15482912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
    Yu XJ; Waeber C; Castanon N; Scearce K; Hen R; Macor JE; Chauveau J; Moskowitz MA
    Mol Pharmacol; 1996 May; 49(5):761-5. PubMed ID: 8622623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC; Ellingboe JW; Lennox WJ; Mazandarani H; Smith DL; Stock JR; Zhang G; Zhou P; Schechter LE
    Bioorg Med Chem Lett; 2005 Jan; 15(2):379-83. PubMed ID: 15603958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro.
    Contesse V; Hamel C; Delarue C; Lefebvre H; Vaudry H
    Eur J Pharmacol; 1994 Nov; 265(1-2):27-33. PubMed ID: 7883026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.
    Mattsson C; Sonesson C; Sandahl A; Greiner HE; Gassen M; Plaschke J; Leibrock J; Böttcher H
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4230-4. PubMed ID: 16055331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of the selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist (+)-(S)-2-chloro-5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3-y l]aniline.
    Suzuki T; Iwaoka K; Imanishi N; Nagakura Y; Miyata K; Nakahara H; Ohta M; Mase T
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):120-2. PubMed ID: 9987833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.
    Bromidge SM; Dabbs S; Davies DT; Davies S; Duckworth DM; Forbes IT; Gaster LM; Ham P; Jones GE; King FD; Mulholland KR; Saunders DV; Wyman PA; Blaney FE; Clarke SE; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Trail B; Riley GJ; Wood MD
    J Med Chem; 2000 Mar; 43(6):1123-34. PubMed ID: 10737744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.
    Borsini F; Bordi F; Poggi A; Di Matteo V
    J Psychopharmacol; 2015 Jul; 29(7):802-11. PubMed ID: 25735994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1 H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents.
    Mokrosz MJ; Mokrosz JL; Duszyńska B; Dereń-Wesołek A; Kłodzińska A; Kowalski P; Charakchieva-Minol S; Tatarczyńska E; Kowalska T; Majka Z; Chojnacka-Wójcik E; Misztal S
    Pharmazie; 1997 Jun; 52(6):423-8. PubMed ID: 9260266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.
    Castro JL; Street LJ; Guiblin AR; Jelley RA; Russell MG; Sternfeld F; Beer MS; Stanton JA; Matassa VG
    J Med Chem; 1997 Oct; 40(22):3497-500. PubMed ID: 9357514
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of carbon-11-labeled 5-HT
    Wang X; Dong F; Miao C; Li W; Wang M; Gao M; Zheng QH; Xu Z
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1836-1841. PubMed ID: 29661535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan.
    Nelson DL; Phebus LA; Johnson KW; Wainscott DB; Cohen ML; Calligaro DO; Xu YC
    Cephalalgia; 2010 Oct; 30(10):1159-69. PubMed ID: 20855361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
    Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
    J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.
    Russell MG; Matassa VG; Pengilley RR; van Niel MB; Sohal B; Watt AP; Hitzel L; Beer MS; Stanton JA; Broughton HB; Castro JL
    J Med Chem; 1999 Dec; 42(24):4981-5001. PubMed ID: 10585208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of novel 2-oxo-1,2-dihydro-3-quinolinecarboxamide derivatives as serotonin 5-HT4 receptor agonists.
    Suzuki M; Ohuchi Y; Asanuma H; Kaneko T; Yokomori S; Ito C; Isobe Y; Muramatsu M
    Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):2003-8. PubMed ID: 11145160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.
    Johnson DE; Rollema H; Schmidt AW; McHarg AD
    Eur J Pharmacol; 2001 Aug; 425(3):203-10. PubMed ID: 11513839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.